The effectiveness of anticoagulant therapy in  COVID-19 associated ischemic stroke

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/2991

Full metadata record

DC Field	Value	Language
dc.contributor.author	Makhsudjan Ataniyazov, Abdulakhad Khamidov.	-
dc.date.accessioned	2022-10-11T07:59:43Z	-
dc.date.available	2022-10-11T07:59:43Z	-
dc.date.issued	2022	-
dc.identifier.isbn	978-1-64945-234-4	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/2991	-
dc.description.abstract	To study and evaluate the effectiveness of various anticoagulant agents on hemorheological indicators in Covid-19 associated ischemic strokes.	en_US
dc.language.iso	en	en_US
dc.publisher	США	en_US
dc.relation.ispartofseries	УДК;	-
dc.subject	Covid-19, ischemic stroke	en_US
dc.title	The effectiveness of anticoagulant therapy in COVID-19 associated ischemic stroke	en_US
dc.type	Thesis	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
8. Атаниязов М.К. Международный тезис 2 январ.pdf	The effectiveness of anticoagulant therapy in COVID-19 associated ischemic stroke	1.07 MB	Adobe PDF	View/Open

DSpace JSPUI